Pevaryl 1% cutaneous powder - mycosis treatment 30 g

Product Description

Pevaryl is an antifungal for the local treatment of all fungal infections, including mixed infections caused by Gram-positive bacteria.

Indications

Pevaryl non-alcoholic cutaneous solution has been specially studied for the treatment of Pityriasis Versicolor; Treatment of the entire body surface makes it possible to eliminate the fungus even where the skin is still apparently healthy.

Pevaryl is indicated in the treatment of:

• skin mycoses caused by dermatophytes, yeasts or molds and infections caused by Gram-positive bacteria;
• mycosis of the ear canal (limited to the emulsion form) and nails;
• Pityriasis Versicolor.

Composition

Active ingredients

econazole nitrate 1.0 g;

Excipients

precipitated silica; perfume no. 4074; zinc oxide; talc.

Directions for use and Dosage

Pevaryl cutaneous powder should be used as a complementary therapy to Pevaryl cream and spray.
cutaneous alcoholic solution. In the case of infections in the intertriginous spaces, the use of Pevaryl cutaneous powder may be sufficient.

Warnings

Keep the medicine out of the reach and sight of children.
All pharmaceutical forms of Pevaryl are indicated for external use only.
Pevaryl is not for ophthalmic or oral use.
In case of sensitization or irritation, discontinue use of the product. Econazole nitrate powder contains talc. Avoid inhalation to prevent irritation of the airways, especially in children and infants.
The spray forms should be applied avoiding inhalation of the product and excessive and improper use.

Interactions

Inform your doctor or pharmacist if you have recently taken any other medicines, even those without a prescription.
Cases of interaction with oral anticoagulants, such as warfarin and
acenocoumarol, have been reported.
In patients undergoing therapy with oral anticoagulants, caution should be exercised and their anticoagulant effect should be monitored more frequently. An adjustment in the dosage of the oral anticoagulant drug may be necessary. may be necessary during treatment with econazole and after its discontinuation.

Pregnancy and breastfeeding

Due to systemic absorption, Pevaryl should not be used during the first trimester of pregnancy unless the doctor considers it necessary for the health of the patient.
Pevaryl can be used during the second and third trimester of pregnancy if the potential benefit to the mother outweighs the possible risks to the fetus.

Storage

Expiry: see the expiry date indicated on the package.
Caution: do not use the product after the expiry date shown on the package.
The expiry date refers to the product in its intact packaging, stored correctly.
Store at a temperature not exceeding 25°C.

Format

30 g powder.